CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,400,000 | -17.5% | 50,000 | 0.0% | 0.02% | -14.8% |
| Q3 2017 | $4,120,000 | -33.3% | 50,000 | -24.2% | 0.03% | -34.1% |
| Q2 2017 | $6,180,000 | +27.7% | 66,000 | -13.2% | 0.04% | +28.1% |
| Q1 2017 | $4,839,000 | +43.3% | 76,000 | 0.0% | 0.03% | +45.5% |
| Q4 2016 | $3,376,000 | – | 76,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |